鴻達興業(002002.SZ):口罩產品獲得美國FDA認證、歐盟CE認證
格隆匯3月27日丨鴻達興業(002002.SZ)公佈,近日,公司子公司江蘇金材科技有限公司收到美國食品藥品管理局(FDA)的通知,公司生產的口罩產品通過美國FDA的認證。同時,公司子公司江蘇金材科技有限公司收到InternationalCertification Registrar授權頒發的歐盟CE符合性聲明文件,公司生產的口罩符合法規標準。
公司表示,此次公司產品通過FDA和CE的認證,標誌着公司生產的口罩產品具備美國、歐盟認證的研發、製造和建立國際質量體系的能力,進一步拓寬了公司的國際市場銷售區域,對公司產品在國際市場的銷售起到了推動作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.